CA Stock MarketDetailed Quotes
MOOD Doseology Sciences Inc
- 0.150
- -0.030-16.67%
15min DelayMarket Closed Dec 13 15:21 ET
660.08KMarket Cap-1.85P/E (TTM)
0.190High0.150Low52.50KVolume0.190Open0.180Pre Close9.94KTurnover0.66052wk High1.24%Turnover Ratio4.40MShares0.07052wk Low-0.081EPS TTM634.88KFloat Cap4.000Historical HighLossP/E (Static)4.23MShs Float0.050Historical Low-0.08EPS LYR22.22%Amplitude--Dividend TTM0.69P/B1Lot Size--Div YieldTTM
Doseology Sciences Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -18.54%-69.81K | 51.12%-235.12K | 88.02%-15.74K | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 71.89%-481.05K | 59.03%-131.33K | 73.47%-95.96K | 97.83%-9.45K |
| Net income from continuing operations | 7.44%-72.27K | 80.92%-339.85K | 90.45%-109.58K | 63.34%-40.54K | 39.27%-111.64K | 77.04%-78.09K | 8.14%-1.78M | -109.35%-1.15M | 79.43%-110.56K | 66.16%-183.85K |
| Operating gains losses | ---- | -98.36%4.14K | ---- | ---- | ---- | ---- | 9,880.02%252.79K | --247K | ---- | ---- |
| Depreciation and amortization | --0 | -69.18%20.37K | 104.37%797 | -97.15%797 | -97.16%797 | -36.45%17.98K | -52.63%66.09K | -165.91%-18.24K | -17.85%27.98K | -40.32%28.07K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | -94.03%12.45K | ---- | ---- | ---- |
| Remuneration paid in stock | 26.05%13.56K | -78.80%17.68K | -184.70%-50.85K | --7.44K | 458.37%50.33K | -25.07%10.76K | -2.94%83.4K | 243.47%60.03K | --0 | -76.67%9.01K |
| Other non cashItems | ---- | -96.05%29.62K | -93.03%48.39K | --0 | ---- | ---- | 888.68%749.17K | 3,572.20%694.49K | -0.73%17.71K | -16.70%18.23K |
| Change In working capital | -16.31%-11.1K | -75.89%32.92K | 356.55%91.37K | 108.08%2.98K | -143.56%-51.88K | -127.77%-9.54K | 148.05%136.58K | 144.13%20.01K | -131.50%-36.88K | 5,928.93%119.09K |
| -Change in receivables | 19.74%-7.34K | -78.34%14.8K | 294.35%11.12K | -241.31%-12.57K | -61.16%25.39K | -3,839.22%-9.14K | 220.01%68.31K | 68.53%-5.72K | 438.95%8.9K | 311.87%65.37K |
| -Change in inventory | 13.12%7.29K | -1,826.64%-31.11K | -15.52%-9.92K | 582.64%17.78K | -825.27%-45.41K | 321.66%6.44K | 104.67%1.8K | -280.41%-8.59K | 43.39%2.6K | 117.88%6.26K |
| -Change in prepaid assets | 22.43%-8.59K | -89.04%15.67K | 152.78%10.7K | -100.01%-4 | -60.96%16.05K | -117.51%-11.07K | 53.66%142.96K | 164.04%4.23K | -44.06%34.38K | -24.40%41.1K |
| -Change in payables and accrued expense | -158.24%-2.46K | 143.89%33.57K | 164.10%79.47K | 97.32%-2.22K | -853.95%-47.91K | 114.01%4.23K | 72.85%-76.49K | 218.84%30.09K | -258.66%-82.77K | -32.85%6.35K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -18.54%-69.81K | 51.12%-235.12K | 88.02%-15.74K | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 71.89%-481.05K | 59.03%-131.33K | 73.47%-95.96K | 97.83%-9.45K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | |||||||
| Net PPE purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
| Net intangibles purchas and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 93.32%-6.14K | -131.54%-6.14K | 0 | 124.34%8.54K | 75.35%-8.54K | 34.41%-91.88K | 156.55%19.46K | -44.79%-41.63K | 47.28%-35.08K |
| Net issuance payments of debt | --0 | 93.32%-6.14K | -132.80%-6.14K | --0 | 124.34%8.54K | 75.35%-8.54K | 23.62%-91.88K | 154.37%18.71K | -42.18%-40.88K | -5.87%-35.08K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 93.32%-6.14K | -131.54%-6.14K | --0 | 124.34%8.54K | 75.35%-8.54K | 34.41%-91.88K | 156.55%19.46K | -44.79%-41.63K | 47.28%-35.08K |
| Net cash flow | ||||||||||
| Beginning cash position | -18.54%1.06M | -30.57%1.3M | -23.44%1.08M | -28.34%1.11M | -22.65%1.23M | -30.57%1.3M | -49.79%1.87M | -36.65%1.41M | -40.84%1.55M | -48.99%1.6M |
| Current changes in cash | -3.53%-69.81K | 57.89%-241.26K | 80.45%-21.87K | 78.69%-29.32K | -175.40%-122.64K | 75.83%-67.43K | 69.18%-572.94K | 68.64%-111.86K | 64.76%-137.59K | 91.20%-44.53K |
| End cash Position | -19.74%990.41K | -18.54%1.06M | -18.54%1.06M | -23.44%1.08M | -28.34%1.11M | -22.65%1.23M | -30.57%1.3M | -30.57%1.3M | -36.65%1.41M | -40.84%1.55M |
| Free cash from | -18.54%-69.81K | 51.12%-235.12K | 88.02%-15.74K | 69.45%-29.32K | -1,288.08%-131.17K | 75.90%-58.89K | 72.02%-481.05K | 59.25%-131.33K | 73.47%-95.96K | 97.85%-9.45K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data